FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2014/07/004750 [Registered on: 22/07/2014] Trial Registered Prospectively
Last Modified On: 15/07/2014
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   COMPLICATIONS OF ABORTION PILLS MISUSE.  
Scientific Title of Study   EVALUATION OF AWARENESS OF ABORTION PILLS AND COMPLICATIONS OF ITS MISUSE.  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Kavita Agarwal 
Designation  Senior Resident 
Affiliation  Deptt. obs. & gynae Safdarjung Hospital, CGHS  
Address  Deptt. Obs. & Gynae, Safdarjung Hospital New Delhi-110029

New Delhi
DELHI
110029
India 
Phone  9990167888  
Fax    
Email  drku93@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sunita Malik 
Designation  Consultant 
Affiliation  Deptt. obs. & gynae Safdarjung Hospital, CGHS  
Address  Deptt. Obs. & Gynae Safdarjung Hospital New Delhi-110029

New Delhi
DELHI
110029
India 
Phone  9818914579  
Fax    
Email  svmalik@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Dr KAVITA AGARWAL 
Designation  Senior Resident 
Affiliation  Deptt. obs. & gynae Safdarjung Hospital, CGHS  
Address  Deptt. Obs. & Gynae Safdarjung Hospital New Delhi-110029

New Delhi
DELHI
110029
India 
Phone  9990167888  
Fax    
Email  drku93@gmail.com  
 
Source of Monetary or Material Support  
NIL 
 
Primary Sponsor  
Name  SAFDARJUNG HOSPITAL 
Address  SAFDARJUNG HOSPITAL, NEW DELHI -110029 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr KAVITA AGARWAL  Safdarjung Hospital   Deptt Obs. & Gynae
New Delhi
DELHI 
9990167888

drku93@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
SAFDARJUNG HOSPITAL  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  ABORTION ,  
 
Intervention / Comparator Agent  
Type  Name  Details 
 
Inclusion Criteria  
Age From  13.00 Year(s)
Age To  45.00 Year(s)
Gender  Female 
Details  1. Women willing to participate in the study.
2. Women with history of abortion pill intake.
 
 
ExclusionCriteria 
Details  NIL 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
• Source of knowledge about abortion pill,
• Patients awareness about the drug, its side effects and complications, need for medical supervision
• Patients considering it as emergency contraceptive measure.
 
august 2014 
 
Secondary Outcome  
Outcome  TimePoints 
• MTP pill taken by patients not eligible for medical abortion,
• Complications arising out of abortion pill misuse like grade of anaemia, patients with incomplete abortions, inevitable abortion, missed abortion.
 
august 2014 
 
Target Sample Size   Total Sample Size="1300"
Sample Size from India="1300" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   31/07/2014 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="9"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NOT PUBLISHED 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  

This would be a cross-sectional study to be conducted in Department of Obstetrics and Gynaecology at Safdarjung Hospital, Delhi, after getting clearance from the ethical committee of the institute.  A sample of 1300 women is required to be recruited in the study. Women willing to participate in the study and with history of abortion pill intake will be included in the study. They will be interviewed by the casualty doctor and their reply will be recorded in a pre structured proforma as per annexure III. The proforma will include questions to decide the eligibility of women to take the abortion pill. The proforma will also include awareness if any, about the drug, its side effects and their management and source of information. Patient condition at the time of admission and treatment given during hospital stay will also be included in the proforma. Data will be analysed with simple parametric tests and the value of P<0.05 will be considered significant.









 
Close